Switch theme
Sign up to access all valuation multiples
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.
2006
83
LTM Revenue $316M
LTM EBITDA $157M
$1.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
PeptiDream has a last 12-month revenue of $316M and a last 12-month EBITDA of $157M.
In the most recent fiscal year, PeptiDream achieved revenue of $310M and an EBITDA of $158M.
PeptiDream expects next 12-month revenue of XXX and NTM EBITDA of XXX
See PeptiDream valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $191M | $310M | XXX | XXX | XXX |
| Gross Profit | $120M | $114M | XXX | XXX | XXX |
| Gross Margin | 63% | 37% | XXX | XXX | XXX |
| EBITDA | $60.1M | $158M | XXX | XXX | XXX |
| EBITDA Margin | 31% | 51% | XXX | XXX | XXX |
| Net Profit | $50.2M | $20.2M | XXX | XXX | XXX |
| Net Margin | 26% | 7% | XXX | XXX | XXX |
| Net Debt | $105M | $18.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, PeptiDream's stock price is JPY 1890 (or $13).
PeptiDream has current market cap of JPY 245B (or $1.6B), and EV of JPY 217B (or $1.4B).
See PeptiDream trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.4B | $1.6B | XXX | XXX | XXX | XXX | $0.78 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, PeptiDream has market cap of $1.6B and EV of $1.4B.
PeptiDream's trades at 4.6x LTM EV/Revenue multiple, and 9.2x LTM EBITDA.
Analysts estimate PeptiDream's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for PeptiDream and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.4B | XXX | XXX | XXX |
| EV/Revenue | 4.6x | XXX | XXX | XXX |
| EV/EBITDA | 9.1x | XXX | XXX | XXX |
| P/E | 16.3x | XXX | XXX | XXX |
| P/E/Growth | 6.6x | XXX | XXX | XXX |
| EV/FCF | 10.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPeptiDream's NTM/LTM revenue growth is 5%
PeptiDream's revenue per employee for the last fiscal year averaged $3.7M, while opex per employee averaged $1.1M for the same period.
Over next 12 months, PeptiDream's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate PeptiDream's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for PeptiDream and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 63% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 51% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 163% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 56% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $3.7M | XXX | XXX | XXX | XXX |
| Opex per Employee | $1.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 20% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 29% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
PeptiDream acquired XXX companies to date.
Last acquisition by PeptiDream was XXXXXXXX, XXXXX XXXXX XXXXXX . PeptiDream acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was PeptiDream founded? | PeptiDream was founded in 2006. |
| Where is PeptiDream headquartered? | PeptiDream is headquartered in Japan. |
| How many employees does PeptiDream have? | As of today, PeptiDream has 83 employees. |
| Who is the CEO of PeptiDream? | PeptiDream's CEO is Mr. Patrick C. Reid. |
| Is PeptiDream publicy listed? | Yes, PeptiDream is a public company listed on TKS. |
| What is the stock symbol of PeptiDream? | PeptiDream trades under 4587 ticker. |
| When did PeptiDream go public? | PeptiDream went public in 2013. |
| Who are competitors of PeptiDream? | Similar companies to PeptiDream include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of PeptiDream? | PeptiDream's current market cap is $1.6B |
| What is the current revenue of PeptiDream? | PeptiDream's last 12-month revenue is $316M. |
| What is the current EBITDA of PeptiDream? | PeptiDream's last 12-month EBITDA is $157M. |
| What is the current EV/Revenue multiple of PeptiDream? | Current revenue multiple of PeptiDream is 4.6x. |
| What is the current EV/EBITDA multiple of PeptiDream? | Current EBITDA multiple of PeptiDream is 9.2x. |
| What is the current revenue growth of PeptiDream? | PeptiDream revenue growth between 2023 and 2024 was 63%. |
| Is PeptiDream profitable? | Yes, PeptiDream is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
